BioCEOsSukk
Nov 12, 11:29 PM
$SCLX $SRNE
IMO and NFA:
After closely monitoring and researching Scilex moves since last September, I'm betting on number 3 below.
Especially because on October 2, just days after Scilex's debt cliff with
$ORMP was due (but has at least publicly remained unpaid), Oramed Execs exchanged underwater options for shares as per their previous shareholder meeting allowed.
Something big is up IMO that will be very beneficial for shareholders of the tickers above, directly for Scilex and indirectly for the other two:
"Connected Cap-Table Cleanup.
Because Oramed holds a senior security interest and consent rights over Semnur's corporate actions, retiring the 12.5 million legal retainer shares on November 4, 2026—just days before Scilex's Q3 2026 10-Q deadline—strongly suggests Scilex, Semnur, and Oramed have been negotiating behind closed doors on:
A debt settlement, asset-backed financing or third-party buyout."
3 replies